Catabasis Pharmaceuticals' Series B Round

Catabasis Pharmaceuticals raised a round of funding on November 15, 2013.

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's dru…

Articles about Catabasis Pharmaceuticals' Series B Round: